Latest Breaking News On - Institutional trading of lexicon pharmaceuticals - Page 1 : comparemela.com

Lexicon Pharmaceuticals (NASDAQ:LXRX) Earns Hold Rating from Needham & Company LLC

Lexicon Pharmaceuticals (NASDAQ:LXRX) Earns Hold Rating from Needham & Company LLC
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Cantor fitzgeraldLeerink partnrsLexicon pharmaceuticalsLexicon pharmaceuticals incNeedham companyLexicon pharmaceuticals stockPrincipal securities incChina universal asset management coInstitutional trading of lexicon pharmaceuticalsCommonwealth equity servicesNational associationNews ratings for lexicon pharmaceuticals dailyFree reportGet free reportEquity servicesChina universal asset management

Lexicon Pharmaceuticals (NASDAQ:LXRX) Upgraded at StockNews com

Lexicon Pharmaceuticals (NASDAQ:LXRX) Upgraded at StockNews com
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Cantor fitzgeraldNeedham companyPrincipal securities incLexicon pharmaceuticals incNational associationLexicon pharmaceuticals stock performanceInstitutional trading of lexicon pharmaceuticalsNews ratings for lexicon pharmaceuticals dailyLexicon pharmaceuticalsChina universal asset management coFree reportGet free reportUniversal asset managementLexicon pharmaceuticals daily

Lexicon Pharmaceuticals (NASDAQ:LXRX) Rating Increased to Sell at StockNews com

Lexicon Pharmaceuticals (NASDAQ:LXRX) Rating Increased to Sell at StockNews com
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Cantor fitzgeraldPinnacle associates ltdNeedham companyLexicon pharmaceuticals tradingNews ratings for lexicon pharmaceuticals dailyChina universal asset management coLexicon pharmaceuticalsLexicon pharmaceuticals incInstitutional trading of lexicon pharmaceuticalsGet free reportFinancial marketsUniversal asset managementLexicon pharmaceuticals daily

Lexicon Pharmaceuticals (NASDAQ:LXRX) Given Hold Rating at Needham & Company LLC

Needham & Company LLC reaffirmed their hold rating on shares of Lexicon Pharmaceuticals (NASDAQ:LXRX – Free Report) in a report published on Thursday morning, Benzinga reports. Lexicon Pharmaceuticals Price Performance NASDAQ LXRX opened at $2.03 on Thursday. The business’s fifty day moving average is $2.42 and its 200 day moving average is $1.68. Lexicon Pharmaceuticals […]

Cantor fitzgeraldNews ratings for lexicon pharmaceuticals dailyBaystate wealth managementLexicon pharmaceuticals price performancePrincipal securities incInstitutional trading of lexicon pharmaceuticalsLexicon pharmaceuticals incLexicon pharmaceuticalsNational associationNeedham companyFree reportGet free reportMontreal canWealth managementPrincipal securitiesLexicon pharmaceuticals daily

Lexicon Pharmaceuticals (NASDAQ:LXRX) Trading Up 11 1%

Shares of Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX – Get Free Report) were up 11.1% on Wednesday . The stock traded as high as $2.23 and last traded at $2.20. Approximately 2,283,560 shares traded hands during mid-day trading, a decline of 52% from the average daily volume of 4,788,254 shares. The stock had previously closed at $1.98. […]

Cantor fitzgeraldInstitutional trading of lexicon pharmaceuticalsBaystate wealth managementLexicon pharmaceuticals incNews ratings for lexicon pharmaceuticals dailyLexicon pharmaceuticals stock performanceLexicon pharmaceuticalsLexicon pharmaceuticals company profileKestra advisory servicesGet free reportMontreal canWealth managementAdvisory servicesPoint capital managementLexicon pharmaceuticals daily